FDA Clears First Point-of-Care Test to Diagnose Diabetes FDA Clears First Point-of-Care Test to Diagnose Diabetes

The Afinion HbA1c Dx assay, for use with the Afinion AS100 Analyzer, is the first rapid point-of-care test cleared to diagnose diabetes and assess a patient ' s risk of developing the disease.FDA Approvals
Source: Medscape Pathology Headlines - Category: Pathology Tags: Diabetes & Endocrinology News Alert Source Type: news